Meet the deranged lunatics that now typify Democrats in

New Post Public Reply Private Reply Replies (1) Message Board
Lmcat
273
Meet the deranged lunatics that now typify Democrats in America, a cesspool of mental illness pretending to be a political party.

Supporters of the Democratic Party have become increasingly unhinged, beginning on Election Night 2016, and Trump Derangement Syndrome remains a thing to this day. In fact, it’s safe to say the affliction is both spreading and deepening among the president’s most vociferous critics.

Witness the recent hearings involving Supreme Court nominee Brett Kavanaugh. Or the doxxing of Republican senators. Or the confrontations involving far-Left agitators and members of President Trump’s Cabinet. The examples are limitless.

And clearly, the Democratic Party leadership, as well as rank-and-file members, must be associated with the haters, the oddballs, the idiots, and the losers because they use them as political pawns to both enhance their own power and attack their political opponents.


Take Julie Swetnick. Represented by porn star lawyer Michael Avenatti, she has accused Kavanaugh and friend Mark Judge of arranging “rape trains” in college by spiking the punch at parties and drugging girls so that Kavanaugh’s buddies could have their way with them.

The allegations in and of themselves are absurd and ridiculous; had Kavanaugh done something even remotely close to that in college the FBI would have found out about long ago during one of the bureau’s six background investigations into his past.

But there she was earlier this week telling NBC News all about it – that is, until she sort of, kind of, did recant the part about being “sure” Kavanaugh was around when the abuse was being meted out.

The party of the sick and demented


In an interview Wednesday with Breitbart Senior Editor-at-Large Rebecca Mansour on SiriusXM’s Breitbart News Tonight, conservative lawyer, commentator, and author Ann Coulter said it was imperative to link “manifest lunatic” Swetnick to the Democrats. (Related: Kavanaugh accuser Christine Blasey Ford ran mass “hypnotic inductions” of psychiatric subjects as part of mind control research funded by foundation linked to “computational psychosomatics” neuro-hijacking.)

“I do not want the Democrats to be able to separate themselves from Julie Swetnick. This is the party of Julie Swetnick. We’ll go with Brett Kavanaugh,” Coulter said. “I’ll take that going into the midterms. I can’t get enough of this lady.”

“This is no longer the party of FDR, Kennedy, and Truman. This is the party of Julie Swetnick,” Coulter made clear. “I’ll take that going into the midterms. I can’t get enough of this lady.”

During the interview, Mansour and Coulter discussed the NBC interview. Mansour pointed out that the interviewer asked Swetnick if she had any witnesses to back up her allegations. Swetnick offered four names, of whom, “one person is dead, the other person has never heard of her, and the two others won’t answer the phone,” Mansour said.

The Democrats also attract supporters who are angry to the point of being deranged.

As NewsTarget reported, Georgetown Distinguished Associate Prof. Christine Fair recently tweeted that GOP members of the Senate Judiciary Committee deserve death because – they’re white and conservative.


“Look at thus [sic] chorus of entitled white men justifying a serial rapist’s arrogated entitlement,” she wrote. In reference to a video depicting “Lindsey Graham’s tirade,” Fair, who claims she is a sexual assault victim (don’t they all?), added, “all of them deserve miserable deaths while feminists laugh as they take their last gasps.”

She added: “Bonus: we castrate their corpses and feed them to swine? Yes.”

And who could forget the “D” list entertainer Kathy Griffin? Last spring she was lambasted by POTUS Trump supporters for posing with a mock severed head of the president – a disgusting act for which she later blamed POTUS Trump.

Threats from the deranged Democrat-aligned Left have become so bad even anti-conservative Facebook was forced to recently remove death threats leveled at Republicans but only after being called out by one of them, Rep. Matt Gaetz, R-Fla.


“Do you remember the shooting at the Republican baseball game? One of those should happen every week,” one post read, a reference to the attempted assassination of GOP members during softball practice for the annual GOP-Democrat game last summer. The shooter nearly killed Rep. Steve Scalise of Louisiana.

These are all people associated with the Democratic Party, which is turning into a magnet for haters, lunatics, the chronically depressed, and the clinically insane.

http://unhinged.news/2018-10-04-meet-the-dera...erica.html

Read more about the Alt-Left direction the Democrats are heading at Alt-Left.news. https://altleft.com/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 9

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 26

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 321

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSyent Inc. to Announce Q3 Financial Results This Month

Updated Category News Views 189

BioSyent Inc. to Announce Q3 Financial Results BioSyent Inc., a prominent player in the specialty pharmaceutical industry, is preparing to release its financial results for the third quarter and year-to-date period. This important announcement is scheduled for November 20, prior to the market opening. The report will cover the company's performance for the three and nine...

Continue Reading
Dr. Ryan Egeland Joins Solventum as Chief Medical Officer

Updated Category News Views 381

Solventum Welcomes Dr. Ryan Egeland as New CMO Solventum, a pioneering healthcare company, recently announced the appointment of Dr. Ryan Egeland, MD, as their Chief Medical Officer. In this significant role, Dr. Egeland will lead the Global Medical and Clinical Affairs team, amplifying clinician and patient voices within the organization. Fostering Collaboration and...

Continue Reading
MiningToken Revolutionizes Cryptocurrency With AI Power

Updated Category News Views 186

Introducing MiningToken's Innovative AI Cloud Mining Service Bitcoin and Ethereum are experiencing remarkable market dynamics as Bitcoin persists in a bullish trend and Ethereum has gained notable ground recently. As global interest in cryptocurrencies grows, effective mining strategies are crucial for profitability. Amidst rising operational costs, many individuals seek...

Continue Reading
Saluda Medical's EVA™ Sensing Technology Approved in Europe

Updated Category News Views 111

Saluda Medical Achieves Regulatory Milestone with EVA™ Technology Saluda Medical, Inc. (ASX:SLD) has made significant strides in the medical device industry by achieving CE certification for its next-generation EVA™ Sensing Technology. This advancement not only marks a major endorsement in Europe but also is recognized in Australia. Following FDA approval in December...

Continue Reading
ReadPartner Inc. Unveils Revolutionary AI Tool to Combat Misinformation

Updated Category News Views 291

ReadPartner Inc. Launches AI Feature to Tackle Misinformation ReadPartner Inc., a leader in AI-driven media intelligence solutions, is excited to announce the upcoming launch of a groundbreaking digital security feature named ProfileScreen. This innovative tool aims to address the pressing issue of misinformation that plagues social media platforms. The ProfileScreen...

Continue Reading